共 34 条
[1]
Cooperberg MR(2010)Time trends and local variation in primary treatment of localized prostate cancer J Clin Oncol 28 1117-1123
[2]
Broering JM(2019)A comparative study of robot-assisted and open radical prostatectomy in 10790 men treated by highly trained surgeons for both procedures BJU Int 123 1031-1040
[3]
Carroll PR(2003)Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer J Urol 169 517-523
[4]
Haese A(2017)Evidenced-based clinical practice guideline for prostate cancer (summary: Japanese Urological Association, 2016 edition) Int J Urol 24 648-666
[5]
Knipper S(2013)Public access NIH Public Access 185 974-81
[6]
Isbarn H(2017)EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent Eur Urol 71 618-629
[7]
Han M(2013)Early salvage radiotherapy following radical prostatectomy Eur Urol 65 1-10
[8]
Partin AW(2018)Establishment of the optimal follow-up schedule after radical prostatectomy Urol Oncol Semin Orig Investig 36 341.e9-341.e14
[9]
Zahurak M(2007)Implications of prostate-specific antigen doubling time as indicator of failure after surgery or radiation therapy for prostate cancer Eur Urol 51 605-613
[10]
Kakehi Y(2017)Determining when to stop prostate specific antigen monitoring after radical prostatectomy: the role of ultrasensitive prostate specific antigen J Urol 197 655-661